ÑÇÖÞAV

A new study by Dongqing Wang, assistant professor of Global and Community Health, finds there is high COVID-19 vaccine hesitancy among adolescents in five sub-Saharan African countries mostly because of perceived lack of safety and perceived lack of effectiveness of COVID-19 vaccines. 

The Fast Grants program within the Mercatus Center will aid in the development of a potential pan-coronavirus vaccine.

ÑÇÖÞAV’s outstanding location, available opportunities, and growing reputation combined to produce a winning formula that attracted statistics professor Lily Wang to the College of Engineering and Computing Department of Statistics in fall 2021.

Mason's Michael Buschmann and his team have developed technology that could help make COVID-19 vaccines less costly, with fewer side-effects and more available.

On Jan. 22, Mason President Gregory Washington spoke with Mason scientists Lance Liotta and Virginia Espina, who head the university’s effort to push the boundaries of technologies that are keeping its three university campuses safe from COVID-19. That includes a rapid-result saliva test, and development of an antibody test that can track a body’s response to the virus and vaccine.